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Abstract
Background—Stress has been shown to suppress ovulation in experimental models, but its 
effect on human reproduction at the population level is unclear.
Methods—Healthy women (n=259), aged 18–44 years from Western New York, were followed 
for two menstrual cycles (2005–2007). Women completed daily perceived stress assessments, a 4-
item Perceived Stress Scale (PSS-4) up to four times each cycle, and a 14-item PSS at baseline. 
Mixed model analyses were used to assess effects of stress on log reproductive hormone 
concentrations and sporadic anovulation.
Results—High versus low daily stress was associated with lower estradiol (-9.5%; 95% 
confidence interval (CI)= -15.6% to -3.0%), free estradiol (-10.4% [-16.5% to -3.9%]), and LH 
(-14.8% = [-21.3% to -7.7%]), and higher FSH (6.2% [2.0% to 10.5%]) after adjusting for age, 
race, percent body fat, depression score, and time-varying hormones and vigorous exercise. High 
versus low daily stress was also associated with lower luteal progesterone (-10.4% [-19.7% to 
-0.10%]) and higher odds of anovulation (adjusted OR = 2.2 [95% CI=1.0 to 4.7]). For each unit 
increase in daily stress level, women had a 70% higher odds of an anovulatory episode (OR=1.7 
[1.1 to 2.4]). Similar but attenuated results were found for the association between the PSS-4 and 
reproductive hormones, while null findings were found for the baseline PSS.
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Conclusion—Daily perceived stress does appear to interfere with menstrual cycle function 
among women with no known reproductive disorders, warranting further research to explore 
potential population-level impacts and causal biologic mechanisms.
Stress among women is common, with 23% of U.S. women reporting high levels of stress 
and nearly 69% reporting stress levels above what is considered healthy.1 Psychosocial or 
perceived stressors, defined as challenges that individuals view as taxing or exceeding their 
coping abilities,2 are of particular concern for women's health, as they can increase the risk 
of adverse health outcomes, including cardiovascular disease, depression, and autoimmune 
disorders.2 Among premenopausal women, prolonged physical stressors such as excessive 
dieting or intensive exercise have been linked to reproductive dysfunction (e.g., 
hypothalamic amenorrhea),3 but the effects of short-term perceived stress on reproductive 
hormones and ovulatory function among healthy eumenorrheic women are unknown.
Multiple pathways have been proposed linking perceived stress with reproductive function, 
including activation of the hypothalamic pituitary adrenal (HPA) axis leading to a delay or 
inhibition of the luteinizing hormone (LH) surge3, and activation of the sympathetic 
medullar system leading to altered blood flow through the fallopian tubes and interrupted 
gamete transport.4 While both nonhuman primate and experimental studies in humans have 
helped inform mechanistic hypotheses,5, 6 few studies have assessed the effects of stress on 
reproductive hormones and menstrual cycle function among premenopausal women; none of 
these prospectively assessed perceived stress or used more than one stress instrument.7, 8 
Global measures of psychosocial stress, such as the Perceived Stress Scale (PSS),9 have 
been used for decades to study relationships between stress and adverse health outcomes. 
However, recent evidence indicates that daily perceived stress captured via diary designs 
have the added advantage of not only reducing memory bias by minimizing the time elapsed 
between an experience and the account of the experience, but also of capturing within-
person changes in perceived stress over time.10,11 Additionally, capturing perceived stress 
via a daily diary is particularly relevant when exploring the temporal relationship between 
stress and menstrual cycle function.12
To better understand the potential effects of multiple psychosocial stressors on reduced 
female fecundity, 4, 13 larger population-based studies with repeated measurements of daily 
stressors, hormones, and ovulation over more than one menstrual cycle are needed. To 
address this gap, we evaluated the association between perceived stress, captured via both a 
daily diary and the PSS, and reproductive function among a cohort of healthy 
premenopausal women.
Methods
The BioCycle Study, conducted in 2005–2007, was a prospective cohort study that followed 
259 premenopausal women from Western New York State for up to two menstrual cycles. 
The study size was based on power to detect differences in oxidative stress levels with 
endogenous reproductive hormone levels and antioxidants, the primary study outcome.14 
The study population and methods have been previously described in detail.14 Briefly, 
women aged 18–44 years with self-reported cycle lengths of 21–35 days for the past 6 
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months, and no previous diagnosis of gynecological or chronic disease, were included in the 
study. Women using long-acting hormone contraception within the past 12 months, or oral 
contraceptives or other hormone supplement within the past 3 months, were excluded, as 
were women who were pregnant or breastfeeding within the past 6 months. Baseline urine 
hCG pregnancy tests (Quick Vue, Quidel Corporation, San Diego, CA, USA) were 
performed to verify that potential study participants were not pregnant. Additionally, women 
could not have a self-reported body mass index (BMI) < 18.5 or >35.0 kg/m2 at screening.14 
Of 449 women who were screened, 318 met the eligibility criteria, and 276 of these 
enrolled. Seventeen women (6%) withdrew before completing the study. Women who 
withdrew were not markedly different from women who completed the study, although a 
greater percentage of Asians (19%) than of blacks (6%) or whites (3%) withdrew. Reasons 
for withdrawal included scheduling conflicts (n = 8), loss to follow-up (n = 4), inability to 
tolerate blood draws (n = 3), inability to participate because of illness (n = 1), or loss of 
interest (n = 1).14 The University at Buffalo Health Sciences Institutional Review Board 
(IRB) approved the study and served as the IRB designated by the National Institutes of 
Health for this study under a reliance agreement. Written informed consent was obtained 
from all participants.
Women provided fasting blood specimens at up to 8 visits/cycle for one (n = 9) or two (n = 
250) menstrual cycles, with visit timing assisted by the use of fertility monitors, which 
tracked urinary levels of estrone-3-glucuronide and LH.15 Scheduled visits corresponded to 
menstruation, mid- and late-follicular phases, LH/follicle-stimulating hormone (FSH) surge, 
expected ovulation, and early-, mid-, and late-luteal phases. Serum estradiol (E2), 
progesterone, LH, FSH, and sex hormone binding globulin (SHBG) were measured via 
Immulite 2000 Solid Phase competitive chemiluminescent enzymatic immunoassay. 
Albumin was measured by the Beckman LX20 auto analyzer using bromcresol purple 
methodology. Free E2 was calculated from total E2, SHBG, and albumin concentrations.16 
All biochemical analyses were conducted by Kaleida Health Laboratories in Buffalo, New 
York. The coefficients of variation for these assays were as follows: <10% for E2, SHBG, 
and insulin; <5% for LH, FSH, and albumin; and <14% for progesterone. Study protocol 
compliance was high, with 94% of the participants completing 7 or 8 visits each cycle. At 
the late-luteal phase visit for each cycle, all women completed a urine hCG pregnancy test; 
no women were pregnant.14
Sporadic anovulation was defined as any cycle with a peak progesterone concentration ≤5 
ng/mL (1 ng/mL = 3.18 nmol/L) and no observed serum LH peak on the mid- or late luteal 
phase visits.17 Participants recorded menstrual bleeding via a daily diary. Menses length was 
defined as a bleeding episode that included ≥ 2 days of bleeding in a 3-day interval preceded 
by at least two bleed-free days 18 and total blood loss on each bleeding day was estimated 
using a standard algorithm.19 Cycle length was calculated as the number of days between 
the first day of menstrual bleeding and the onset of the next menses for each cycle. Day of 
ovulation among ovulatory cycles was assigned based on dates and levels of the LH peak 
using the fertility monitor compared with the observed LH maximum value in serum and the 
first day of progesterone rise. For anovulatory cycles, the day of ovulation was set at day 14 
for comparison purposes only. Follicular phase length was defined as day 1 of bleeding to 
Schliep et al. Page 3






















the day of ovulation. Luteal phase length was defined as day of ovulation through the day 
before the next menses.
Participants prospectively recorded stress levels (not stressful [1], a little stressful [2], very 
stressful [3]) using a daily diary over the course of the two menstrual cycles. Participants 
also completed a 14-question PSS (PSS-14) assessment at baseline to measure stress in the 
previous month; and a 4-item PSS (PSS-4) assessment at 4 of the clinic visits corresponding 
to menstruation, the mid-follicular phase, expected ovulation, and mid-luteal phase to 
measure stress in the previous week. The PSS measured the degree (via a five-point scale 
from never to very often) to which situations in one's life are appraised as stressful.9 The 
majority of participants (89%) completed ≥75% of their daily diaries. All but one woman 
completed the baseline PSS-14 assessment, while 90% of women completed all four PSS-4 
assessments during each cycle.
Four 24-hour dietary recalls were administered at the same clinic visits as the 4-item PSS. 
Food and beverage intake information was collected, and nutrient data were analyzed using 
the Nutrition Data System for Research (version 2005; Nutrition Coordinating Center, 
University of Minnesota). Total energy intake (kcals/day), fiber (grams/day), alcohol 
(grams/day), caffeine (mg/day), and the alternate Mediterranean Diet Score20 were 
calculated for each dietary assessment. Minutes of vigorous exercise, daily sexual activity 
(defined as vaginal intercourse), sleep duration, cigarette use, and medication use were 
assessed from the daily diary. Total caffeine intake was calculated as the sum of dietary and 
medication-based caffeine.21
Age, race, income, education level, sexual and reproductive history, and depression (Center 
for Epidemiologic Studies Depression Scale, CES-D) were obtained at baseline using 
standard questionnaires.14, 22 Race was considered because previous research has shown that 
reproductive hormone metabolism and perceived stress vary by race.23, 24 At the end of the 
follow-up period, total percent body fat was measured using duel energy X-ray 
absorptiometry scans.
Two of the 509 cycles (<1%) were missing daily diary stress information and were excluded 
from all analyses. Descriptive statistics were compared among tertiles of daily stress 
averaged over the study period by using ANOVA for normally distributed continuous 
variables and the Wilcoxon-Mann-Whitney test for non-normally distributed continuous 
variables. Fisher's exact tests were used for categorical variables.
Linear mixed models were used to evaluate the association between daily stress and log 
serum concentrations of E2, progesterone, LH and FSH, both over the entire cycle and 
restricted to follicular and luteal phases, including all cycles. We analyzed cycle phases 
separately because previous research has shown stress to be associated with changes in 
phase-specific hormone concentrations.7 We averaged daily stress levels reported for the 5 
days before each clinic visit (hereafter referred to as “recent daily stress”), as this reduced 
intra-individual variability and was comparable to the recall window for the PSS-4. Daily, 
PSS-4, and PSS-14 stress levels were analyzed as continuous and dichotomous measures 
(high stress, > the median; low stress, ≤ median). For better comparison between continuous 
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stress measures with different scales, results are presented as a one-standard-deviation 
increase in stress level for each measure.
Our final models were adjusted for age, percent body fat, race, baseline depression score, 
and time-varying vigorous exercise. Because E2, progesterone, LH, and FSH concentrations 
change over the cycle in response to complex feedback mechanisms with other hormones 
and because that fluctuation in these hormones may change stress vulnerability,25 traditional 
regression adjustment for other hormone concentrations across the cycle may be inadequate. 
Additionally, time-varying exercise could be both a cause and consequence of time-varying 
perceived stress. Therefore, we also conducted analyses using marginal structural models 
that adjusted for other reproductive hormones and exercise through stabilized inverse-
probability-of-exposure weights 26, 27 to appropriately account for time-varying 
confounding by hormones and exercise affected by prior stress levels. Weighted linear 
mixed-effects models with random intercepts were used to estimate the parameters of the 
marginal structural models.
Generalized linear mixed models with random intercepts were used to estimate odds ratios 
(ORs) for the association between each measure of stress (average daily stress, PSS-4, and 
PSS-14 scores; analyzed continuously and dichotomously [above and below the median]) 
and anovulation, while adjusting for age, percent body fat, race, vigorous exercise, and 
depression score. We assessed daily and PSS-4 stress measures, along with vigorous 
exercise, up until ovulation so as to best preserve the temporal cause and effect order.
We conducted several sensitivity analyses to evaluate the robustness of our initial results. To 
assess if there remained residual confounding, we additionally adjusted for other baseline 
and time-varying factors such as sleep duration, sexual activity, pain or antibiotic 
medication use, caffeine and alcohol intake, cigarette use, nulligravidity, total energy and 
fiber intake, and the alternate Mediterranean Diet Score, and we compared the resulting 
effect estimates with our original analysis. We also compared our final adjusted model to 
one excluding baseline depression score to evaluate its impact on our findings. Average 
stress levels over the past 2 days instead of 5 days before each clinic visit, and stress 
reported on each of the 5 days preceding the clinic visit, were examined to see how varying 
the exposure window affected our reproductive hormone estimates. Effect modification was 
evaluated for age quartiles (18–20, >20–24, >24–35, >35 years) and race (white, black, 
Asian, and other) by fitting multiplicative interaction terms of these factors with perceived 
stress in multivariate models.
In regard to the effect of stress on ovulatory function, sensitivity analyses were conducted to 
assess the effect of stress on anovulation using a more conservative definition that included 
any cycle with a peak progesterone concentration ≤3 ng/mL and no observed serum LH 
peak on the mid- or late luteal phase visit.17 Additionally, we conducted a case-crossover 
analysis among the women with both an ovulatory and anovulatory cycle during the study 
period (n=21) who recorded daily stress during the first half of their menstrual cycle. 
Conditional logistic regression was used to calculate the matched OR for anovulation by 
dichotomized stress levels while adjusting for time-varying factors within the cycle.28, 29 
Case-crossover studies control for baseline factors by design; thus age, percent body fat, 
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race, and baseline depression score were not included in our adjusted analyses. All analyses 
were performed in SAS, version 9.3, software (SAS Institute, Inc., Cary, North Carolina).
Results
Over the study period, women in the BioCycle Study reported 59% of days as not stressful, 
32% as a little stressful, and 8% as very stressful, according to the daily diaries. Geometric 
mean concentrations, averaged over the menstrual cycle, of total and free estradiol were 
87.1pg/mL (95% confidence interval [CI] = 83.6 to 90.8; range, 30.6 - 212.2) and 1.3pg/mL 
(CI = 1.2 to 1.3; range = 0.5 - 3.8) respectively; progesterone 1.4ng/mL (CI = 1.4 to 1.5; 
range = 0.2 - 3.1); LH, 6.4 ng/mL (CI = 6.2 to 6.7; range = 2.1 - 16.6); and FSH, 5.2 
mIU/mL (CI = 5.0 to 5.4; range = 1.9 - 13.5). Average daily stress was positively associated 
with depressive symptoms (P<0.001), level of education (P=0.02), and having at least one 
anovulatory cycle (P=0.04) (Table 1). No associations were found between daily stress and 
demographic, lifestyle, dietary, and other menstrual cycle characteristics.
High recent daily stress was associated with lower estradiol (-9.5% [95% CI = -15.6% to 
-3.0%]), free estradiol (-10.4% [-16.5% to -3.9%]), luteal progesterone (-10.4% [-19.7% to 
-0.10%]), and LH (-14.8% [-21.3% to -7.7%]), and higher FSH (6.2% [2.0% to 10.5%]) 
concentrations after adjusting for age, race, percent body fat, depression score, and time-
varying daily vigorous exercise and hormones compared with women with low recent daily 
stress (Figure). Continuous evaluation by cycle phase indicated that recent daily stress was 
associated with lower total and free E2 and LH during the follicular phase and with lower 
progesterone and higher FSH during the luteal phase. Specifically, for each one standard 
deviation increase in recent daily stress level, follicular total and free estradiol and follicular 
LH decreased by log -0.08 pg/mL (-0.12 to -0.04), -0.09 pg/mL (-0.12 to -0.05), and -0.07 
ng/mL (-0.11, -0.03), respectively; luteal progesterone decreased by log -0.05 ng/mL (-0.11 
to 0.01), and luteal FSH increased by log 0.04 mIU/mL (0.01 to 0.07) (Table 2). Similar, 
albeit attenuated, estimates were observed for the association between the PSS-4 and 
reproductive hormones with each standard deviation unit increase in PSS-4 associated with 
decreased log follicular free estradiol (β = -0.06 [95% CI = -0.09 to -0.001]) and LH (-0.06 
[-0.12 to -0.03]); null findings were found for the baseline PSS-14. Our results were not 
appreciably altered by adjusting for other potential confounding factors individually, 
removing baseline depression score as a confounding factor, or assessing alternative 
exposure windows for daily stress prior to the clinic visit. No significant interactions 
between stress and age or race were identified (P>0.05).
Sporadic anovulation was observed in 40 (7.9%) of the 507 cycles in this analysis. Women 
with high daily stress up until ovulation had greater odds of anovulation than women with 
low stress (adjusted OR = 2.3 [95% CI = 1.0 to 4.7]) after controlling for age, race, percent 
body fat, daily vigorous exercise, and depression score (Table 3). We found near-null 
relationships between the dichotomized 4- and 14-item PSS and anovulation. When assessed 
continuously, we found that for each increase in daily stress level, on average women had a 
70% increased adjusted odds of an anovulatory episode (OR=1.7 [1.1 to 2.4]). Near-null 
associations were found for the 4- and 14-item PSS continuous assessment and anovulation. 
Similar but attenuated estimates were found when assessing (1) daily and PSS stress and (2) 
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odds of anovulation based on the more conservative criterion for defining ovulation (data 
not shown). Women included in the case-crossover analysis (n=21) had a higher, increased 
odds of sporadic ovulation (OR = 3.0; P=0.24) for cycles with high versus low daily stress.
Discussion
We found that high daily stress was associated with lower total and free E2, LH, luteal 
progesterone, and higher FSH concentrations, and increased odds of sporadic anovulation, 
as compared with low stress. While it has long been demonstrated that severe stress under 
experimental conditions or among individuals sharing specific stressors can adversely affect 
female reproductive function,6 this is the first study to demonstrate that everyday stress 
among healthy women with no known reproductive disorders is linked to altered 
reproductive function. Our findings for daily, but not baseline, perceived stress indicate that 
it is recent stress that has the greatest impact on menstrual cycle parameters, including 
ovulatory function.
Our findings support the hypothesis that stress activates the HPA axis, leading to an 
inhibition of the requisite preovulatory LH surge, and consequent suppression of ovulation 
as evidenced by higher FSH levels.30–32 However, alternative pathways may affect 
reproductive function, such as activation of the sympathetic-adrenal medullary axis leading 
to altered blood flow and interrupted gamete transport.4 Given previous research showing a 
reduction in fecundability mediated via the sympathetic-adrenal medullary pathway, further 
research in this evolving area is warranted.4
We are aware of only two previous epidemiologic studies assessing the effects of stress on 
reproductive hormones and menstrual cycle function among premenopausal women.7,8 
Similar to our findings of increased stress associated with decreased luteal progesterone 
levels, a study among 24 parous Mayan women not on hormonal contraception found that 
increased physiologic stress, as measured via cortisol, was associated with decreased urinary 
prenandiol during the luteal phase.7 Contrary to our findings pertaining to daily stress and 
anovulation, another study among 276 healthy, premenopausal U.S. women found that 
psychological stress in the workplace was not associated with ovulatory function.8 However, 
this prior study only assessed job-related stress measured at baseline.8 When using the 
baseline PSS-14 assessment, we, too, found no association between perceived stress and 
ovulatory function. The assessment of everyday psychosocial stress captured daily over the 
course of the entire menstrual cycle may more accurately capture how a woman reacts 
physically to daily stressors compared with a single baseline measurement found to have 
poor correlation with fecundity.33 Indeed, we found only slight to fair agreement34 between 
baseline PSS-14 and average daily stress tertiles (κ=0.21 [95% CI = 0.12 – 0.29]) and 
relatively poor correlation (r=0.31). Furthermore, our similar but attenuated estimates with 
the PSS-4 and reproductive hormones compared with average prior 5-day daily perceived 
stress (with only moderate agreement between tools, κ=0.46 [95% CI = 0.38 to 0.53],34 and 
moderate correlation, r=0.53) suggests that it is not only the timing of the stress 
measurement tool that matters but also the tool used. While the PSS has been validated in 
many populations for chronic disease, its use to measure reproductive function, particularly 
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among healthy women, has not been validated. While previous research highlights the 
strengths of capturing stress through diary designs,10, 11 future validation work is needed.
An association of perceived stress with reproductive hormones and ovulatory function has 
substantial implications for women's health, if established by further research. Alterations in 
gonadotropins and gonadal steroids are known to affect a woman's chance of 
conceiving.3, 35 However, studies assessing the effect of psychosocial stress on female 
fecundity via the HPA axis, among women not undergoing in vitro fertilization, have been 
inconsistent to date.33, 36 Mixed findings could be attributable to both variation in 
assessment time points and differences in psychosocial stress measurement tools and/or 
threshold scores.37 Future studies looking to investigate the effects of perceived stress on 
female fecundity would be advised to measure recent stress and make certain that 
assessment tools are validated with physiologic measures in the population of interest.33
The BioCycle Study had several strengths including a prospective study design; large 
sample size (both in number of women and number of cycles) for assessing the effects of 
repeated measurements of perceived stress on reproductive hormones and ovulatory 
function; various tools for psychosocial stress assessment; and well-measured confounding 
factors associated with stress and reproduction. Nevertheless, this study was confined in its 
ability to take advantage of the powerful case-crossover analyses due to the limited number 
of women with both an ovulatory and anovulatory episode, as well as due to the relatively 
few women reporting high levels of stress compared with the national average.1 While we 
were limited in power to detect a difference in our case-crossover analyses, our prospective 
assessment of daily stress helped reduce any misclassification bias for all of our analyses. A 
larger epidemiologic study following women for more than two cycles should be considered. 
We do acknowledge that women with higher perceived stress levels may be less likely to 
complete their daily diaries; however, given the associations we found between daily 
perceived stress and suppression of estradiol, progesterone, LH, and ovulation, we expect 
that we may be underestimating, versus overestimating, the effect of stress on menstrual 
cycle function. A larger epidemiologic study assessing women's daily perceived stress levels 
and menstrual cycle function, following women for more than two cycles, should be 
considered.
In regard to the generalizability of our findings, although the BioCycle Study's racial/ethnic 
makeup was fairly representative of the US population with the exception of Hispanics,38 
women in our study were of higher socioeconomic status as reflected in 87% having post-
secondary education or above compared with 59% for US adult females.38 Although 
previous large population-based studies have corroborated our findings regarding the inverse 
relationship between education level and perceived stress,39 future work looking at the 
effects of stress on women's reproductive health should be expanded to include women of 
less privileged backgrounds who may experience more severe or alternative forms of 
psychosocial stress.
In summary, higher perceived daily stress levels among this cohort of healthy 
premenopausal women were associated with lower concentrations of total and free E2, LH, 
and luteal progesterone, higher concentrations of FSH, and increased odds for sporadic 
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anovulation, after taking into account important baseline and time-varying confounding 
factors. While our study was not designed to assess the mechanism by which stress might 
lead to reproductive dysfunction, we were able to demonstrate that daily perceived stress 
does interfere with normal menstrual cycle function, warranting further research to explore 
potential population-level impacts and causal biologic mechanisms.
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Analyses were conducted using weighted linear mixed models and adjusted for age, race, 
percent body fat, depression score, and time-varying daily vigorous exercise and concurrent 
reproductive hormones. FSH, follicle-stimulating hormone; LH, luteinizing hormone. 
Results are presented as average percent change in nontransformed reproductive hormone 
values for high versus low stress using the following formula: (exp (β) − 1) × 100%
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Table 1
Characteristics of women participating in the BioCycle Study by tertile of average daily 
stress (n=259 women)a
Daily Stress Tertile
Low (1-1.31) (n=87) Moderate (>1.31–1.63) (n=87) High (>1.63–2.73) (n=85) P
Demographic/Lifestyle
Age (years); mean (SD) 28.3 (8.4) 27.0 (8.0) 26.5 (8.2) 0.34
Race; no. (%) 0.22
 White 51 (33) 47 (31) 56 (36)
 Black 20 (39) 22 (43) 9 (18)
 Asian 10 (27) 12 (32) 15 (41)
 Other 6 (35) 6 (35) 5 (29)
Hispanic; no. (%) 5 (6) 3 (3) 3 (4) 0.80
Income; no. (%) 0.06
 <$39,999 45 (52) 45 (52) 28 (33)
 $40 000–74 999 20 (23) 24 (28) 28 (33)
 >75 000 22 (25) 18 (21) 29 (34)
Education; no. (%) 0.02
 ≤ High School 14 (16.1) 15 (17.2) 4 (4.7)
 Post-secondary 73 (83.9) 72 (82.8) 81 (95.3)
Married; no. (%) 24 (27.6) 20 (23.0) 22 (25.9) 0.78
Percent body fat; mean (SD) 29.4 (5.9) 29.1 (6.1) 30.0 (5.8) 0.95
Hormonal contraception ever; no. (%) 47 (34) 49 (35) 44 (31) 0.83
Nulligravid; no. (%) 57 (32) 64 (36) 56 (32) 0.33
Nulliparous; no. (%) 60 (32) 68 (36) 61 (32) 0.15
Depression score; median (IQR) 3 (0-6) 4 (1-8) 6 (3-11) <0.0 01
Current smoker; no. (%) 14 (33) 13 (31) 15 (36) 0.89
Sleep (hours); mean (SD) 7.3 (0.7) 7.4 (0.7) 7.2 (1.4) 0.72
Vigorous exercise (min/day); median (IQR) 8.2 (0.7 -20.0) 10.7 (3.2 -17.5) 10.6 (2.8 - 22.3) 0.46
Pain medication use; no. (%) 55 (31.4) 67 (38.3) 53 (30.3) 0.07
Antibiotic medication use; no. (%) 7 (38.9) 3 (16.7) 8 (44.4) 0.24
Sexual activity; no. (%)
 Never 15 (25) 22 (37) 22 (37)
 Previous, not current 27 (42) 20 (31) 17 (27)
 Sexually active (<1/week) 22 (32) 23 (33) 24 (35) 0.63
 Sexually active (≥1/week) 23 (37) 20 (32) 20 (32)
Diet
Total energy (kcal); mean (SD) 1550.2 (345.8) 1684.9 (368.8) 1604.6 (378.4) 0.05
Alcohol (g); median (IQR) 0.08 (0.02, 3.9) 0.07 (0.02, 2.3) 0.14 (0.02, 4.2) 0.49
Mediterranean Diet Score; mean (SD) 2.7 (0.8) 2.8 (0.9) 3.0 (1.1) 0.12
Fiber (g/day); mean (SD) 12.8 (4.1) 13.6 (6.1) 14.5 (6.2) 0.14
Caffeine (mg/day); median (IQR) 51.7 (16.4, 147.7) 71.1 (23.3, 156.2) 49.7 (16.7, 134.1) 0.69
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Daily Stress Tertile
Low (1-1.31) (n=87) Moderate (>1.31–1.63) (n=87) High (>1.63–2.73) (n=85) P
Menstrual Cycle Characteristics
Menses Length (days); mean (SD) 6.9 (1.5) 7.0 (1.5) 7.0 (1.9) 0.94
Blood loss (mL); median (IQR) 55.0 (30.8 - 85.5) 55.0 (27.5 - 78.0) 53.5 (30.0 - 80.5) 0.91
Cycle length (days); mean (SD) 28.5 (2.7) 28.9 (3.0) 28.9 (4.3) 0.72
Anovulatory (cycles); no. (%) 6 (17) 12 (34) 17 (49) 0.04
Abbreviations: IQR, interquartile range
a
Participants were asked to record their level of stress each day: 1 = not stressful; 2 = a little stressful; and 3 = very stressful. In Table 1, stress was 
averaged for each woman over the entire study period and categorized into tertiles (low, moderate, and high stress). All except baseline 
characteristics are averaged over the study period and compared between tertiles of daily stress. Analysis of variance for normally distributed 
continuous variables, Wilcoxon-Mann-Whitney test for non-normally distributed continuous variables; and Fisher's exact tests for categorical 
variables were used to test associations.
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Table 2
Mean difference in log serum concentrations of reproductive hormones according to one-
standard-deviation continuous change in stress levela (n=507 cycles)
Log Hormone Daily Stress β (95% CI) PSS-4 (cycle) β (95% CI) PSS-14 (baseline) β (95% CI)
Estradiol (pg/mL)b
 Follicular -0.08 (-0.12 to -0.04) -0.03 (-0.09 to 0.03) 0.02 (-0.07 to 0.07)
 Luteal -0.01 (-0.04 to 0.03) 0.03 (-0.03 to 0.06) 0.05 (-0.01 to 0.14)
Free Estradiol (pg/mL)b
 Follicular -0.09 (-0.12 to -0.05) -0.06 (-0.09 to -0.001) 0.00 (-0.07 to 0.07)
 Luteal 0.00 (-0.08 to 0.07) 0.01 (-0.03 to 0.03) 0.03 (-0.02 to 0.14)
Progesterone (ng/mL)b
 Luteal -0.05 (-0.11 to 0.01) 0.00 (-0.09 to 0.09) 0.02 (-0.07 to 0.14)
FSH (mIU/mL)b
 Follicular 0.01 (-0.01 to 0.03) 0.01 (-0.03 to 0.03) 0.02 (-0.03 to 0.06)
 Luteal 0.04 (0.01 to 0.07) 0.03 (-0.01 to 0.06) 0.01 (-0.07 to 0.07)
LH (ng/mL)b
 Follicular -0.07 (-0.11 to -0.03) -0.06 (-0.12 to -0.03) -0.03 (-0.07 to 0.07)
 Luteal 0.03 (-0.01 to 0.07) 0.01 (-0.06 to 0.06) -0.06 (-0.14 to 0.01)
a
Analyses conducted using linear mixed models adjusting for age, race, percent body fat, depression score, and daily vigorous exercise. Overall, 
there were 3891 (95.9%) measurements of each reproductive hormone collected from up to 16 clinic visits for the 259 women.
b
International System of Units (SI) conversion, estradiol: 1 pg/mL = 3.67 pmol/L; progesterone: 1 ng/mL = 3.18 nmol/L; LH: 1 ng/mL = 4.34 
mIU/L; FSH 1 mIU/ml = 1 IU/L.
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